Medpace Holdings, Inc.·4

Nov 18, 5:02 PM ET

Kraft Robert O. 4

4 · Medpace Holdings, Inc. · Filed Nov 18, 2025

Insider Transaction Report

Form 4
Period: 2025-11-14
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-14$54.99/sh+6,472$355,8957,305 total
  • Sale

    Common Stock

    2025-11-14$591.85/sh6,472$3,830,453833 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-146,4720 total
    Exercise: $54.99Exp: 2026-05-17Common Stock (6,472 underlying)
Footnotes (2)
  • [F1]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $588.98 to $596.543. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
  • [F2]The option vested in full on May 14, 2020.

Documents

1 file
  • 4
    wk-form4_1763503345.xmlPrimary

    FORM 4